Crisaborole Ointment for Skin Toxicity Induced by Cetuximab

Clinical trial NCT06118047 · UNKNOWN

Trial details

NCT number: NCT06118047
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Cetuximab Skin Toxicity

Start date: 2023-08-01
Primary completion: 2024-12-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.